- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/455 - Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides
Patent holdings for IPC class A61K 31/455
Total number of patents in this class: 1516
10-year publication summary
127
|
137
|
139
|
146
|
167
|
131
|
186
|
177
|
170
|
44
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Société des Produits Nestlé S.A. | 9672 |
48 |
DSM IP Assets B.V. | 5856 |
23 |
Turtle Bear Holdings, LLC | 78 |
18 |
Conaris Research Institute AG | 35 |
16 |
AstraZeneca AB | 3042 |
15 |
io Therapeutics, Inc. | 112 |
14 |
The Regents of the University of California | 18943 |
12 |
F. Hoffmann-La Roche AG | 7958 |
11 |
Conopco, Inc. | 4644 |
9 |
Almirall, S.A. | 534 |
9 |
Astellas Pharma Inc. | 1145 |
9 |
The Procter & Gamble Company | 22178 |
8 |
International IP Holdings LLC | 73 |
8 |
The General Hospital Corporation | 4517 |
7 |
Takeda Pharmaceutical Company Limited | 2961 |
7 |
Beth Israel Deaconess Medical Center, Inc. | 844 |
7 |
ChromaDex Inc. | 84 |
7 |
Nutri Co., Ltd. | 49 |
7 |
Shionogi & Co., Ltd. | 914 |
7 |
Washington University | 1473 |
7 |
Other owners | 1267 |